What's New

December begins the holiday season in NY for Target Health with red poinsettias everywhere in our offices on Madison Avenue. Holiday wishes to all.

Our very good friend and colleague, Dr. Scott Mellis, Vice President, Early Clinical Development and Experimental Sciences, Rare Diseases at Regeneron Pharmaceuticals, took an adventurous trip to Africa and came back with some extraordinary photos.

We hope to see you in Chicago and join us on our couches.

This is a must for those interested in clinical trials of the future.

Last week, Target Health was honored as Dr. Jules Mitchel joined Dr. John Laschinger (FDA), for a Clinical Trials Transformation Initiative (CTTI) Webinar on CTTI's recommendations on how to design and use registries for prospective clinical trials. The Webinar attracted more than 200 participants and the questions from the attendees were all "on target." According to the CTTI website, "CTTI's recommendations for registry assessment and design can assist in making embedded clinical trials suitable for regulatory purposes. By using registries as a reusable platform for evidence generation, we can improve the efficiency of clinical trials and bring new treatments to patients faster."

Warren Pearlson, our esteemed Director of Business Development, visited Iceland recently and came back with some fantastic photos the he and a colleague took. Fortunately for Target Health, Dr. Mitchel will be presenting on the topic of EHR/EDC integration in Iceland in a few weeks at the Spring meeting of the eClinical Forum. Hope to see you there.

Target Health will again be attending the 16th MIXiii-BIOMED 2017 Conference and Exhibition, being held at the David Intercontinental, (May 23-25, 2017) in Tel-Aviv. This is the 16th anniversary of the conference which we have been attending since 2009. We have many clients and friends in Israel, so please let us know if you will be attending. We look forward to getting together and having a coffee.

By Joyce Hays, MS and Jules Mitchel, MBA, PhD